The Drug Discovery World Podcast Drug Discovery World (DDW)

Today’s episode is titled, “Overcoming different barriers in drug discovery", which covers three articles written for Volume 23, Issue 3 – Summer 2022 of DDW. They are called “Addressing the challenge of salt forms in drug discovery”, “A different approach: reimagining biology”, and “Women in Discovery: championing female leaders across drug discovery”.
In the first article, you will hear from Andrievs Auseklis Auzin, Developer, Molport, Latvia. In the second article, you will hear from three key members of the Evonetix team. In the third article, you will hear from SciPro’s Jessica Woodgate and Molly Edwards.

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. 
As we approach another autumn/winter season in the northern hemisphere, Covid-19 vaccines are once again making the headlines, but in the last week we have also reported on vaccine trials for a number of other conditions, including Nipah virus, rabies and lung cancer.
You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts. 

In the In Conversation With series, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business.   
In this episode, Megan Thomas is in conversation with Shelley Ackerman, a biological engineer turned immunologist with a passion for drug discovery and development. She has been honoured as one of MIT Technology Review's Innovators Under 35 (2021), STAT Wunderkind (2021), and San Francisco Business Times' Women Who Lead in Life Sciences, The Next Generation of Life Sciences Researchers (2022), and today she speaks about the work being carried out at Bolt BioTherapeutics, where she is the Director & Program Team Lead.

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. 
This week we have seen the vital importance of collaboration to the successful development and discovery of novel therapeutics, exemplified by the new deal agreed by the UK and EU to admit the UK back into Horizon Europe, the largest collaborative research programme in the world.
You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts. 

Today’s episode is titled, “How is mass spectrometry advancing drug discovery?", which covers two articles written for Volume 23, Issue 3 – Summer 2022 of DDW. They are called “Native mass spectrometry: Drug discovery’s new kid on the block”, and “Addressing the developability gap in pharma”.
In the first article, you will hear from Id-leer Liko, klee-tos Sokratous & Miguel Silva at OMass Therapeutics.
In the second article, you will hear from Susan Darling, Senior Director, CE and Biopharma, SCIEX and Todd Stawicki, Senior Global Marketing Manager, Biopharma, SCIEX.

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. 
This week’s headline news features a stem-cell derived Parkinson’s therapy, a monoclonal antibody for head and neck cancer, an estrogen receptor degrader for breast cancer, a mitochondrial activator for long Covid, and the world’s first AI-designed bispecific T cell engager – reflecting the breadth of innovative approaches to disease being employed by researchers across the globe.
You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.